- Presentations
- 6
- Markets
- 1
ProHance is a brand of Gadoteridol marketed by Bracco Diagnostics, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Gadoteridol
- Brand owner
- Bracco Diagnostics
- Registered in
- United States
- Strengths and forms
- 1396.5 mg/5 mL injection, 13965 mg/50 mL injection, 2793 mg/10 mL injection, 27930 mg/100 mL injection, 4189.5 mg/15 mL injection, 5586 mg/20 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| ProHance 1396.5 mg/5 mL injectionIntravenous | Bracco Diagnostics | US FDA | Available on request |
| ProHance 13965 mg/50 mL injectionIntravenous | Bracco Diagnostics | US FDA | Available on request |
| ProHance 2793 mg/10 mL injectionIntravenous | Bracco Diagnostics | US FDA | Available on request |
| ProHance 27930 mg/100 mL injectionIntravenous | Bracco Diagnostics | US FDA | Available on request |
| ProHance 4189.5 mg/15 mL injectionIntravenous | Bracco Diagnostics | US FDA | Available on request |
| ProHance 5586 mg/20 mL injectionIntravenous | Bracco Diagnostics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request ProHance
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.